Brief: Generation Bio Reports Q4 And Full Year 2021 Results
Feb 24 (Reuters) - Generation Bio Co GBIO.O :
* GENERATION BIO OUTLINES 2022 STRATEGIC PRIORITIES AND
REPORTS
FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS
* Q4 LOSS PER SHARE $0.54
* Q4 EARNINGS PER SHARE VIEW $-0.57 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXbfrc7r
Further company coverage: GBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Generation Bio
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Nodthera Appoints Geoff Mcdonough, M.D., As Independent Board Member